Works matching IS 14783223 AND DT 2022 AND VI 42 AND IP 12
Results: 41
Issue Cover.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. i, doi. 10.1111/liv.15484
- By:
- Publication type:
- Article
Treatment patterns for hepatocellular carcinoma in patients with Child–Pugh class B and their impact on survival: A Korean nationwide registry study.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2830, doi. 10.1111/liv.15464
- By:
- Publication type:
- Article
FBXO31 sensitizes cancer stem cells‐like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2871, doi. 10.1111/liv.15462
- By:
- Publication type:
- Article
Organophosphate pesticide exposure and biomarkers of liver injury/liver function.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2713, doi. 10.1111/liv.15461
- By:
- Publication type:
- Article
Inhibition of HSPA8 by rifampicin contributes to ferroptosis via enhancing autophagy.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2889, doi. 10.1111/liv.15459
- By:
- Publication type:
- Article
Lipid droplets as the genetic nexus of fatty liver.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2594, doi. 10.1111/liv.15460
- By:
- Publication type:
- Article
A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2843, doi. 10.1111/liv.15458
- By:
- Publication type:
- Article
Human poliovirus receptor contributes to biliary atresia pathogenesis by exacerbating natural‐killer‐cell‐mediated bile duct injury.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2724, doi. 10.1111/liv.15457
- By:
- Publication type:
- Article
Curable response to crizotinib in a patient with liver metastatic inflammatory myofibroblastic tumour carrying a TFG‐ROS1 fusion.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Causal relationships between metabolic‐associated fatty liver disease and iron status: Two‐sample Mendelian randomization.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2759, doi. 10.1111/liv.15455
- By:
- Publication type:
- Article
Extrahepatic autoimmune diseases do not increase the mortality of autoimmune hepatitis.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2909, doi. 10.1111/liv.15454
- By:
- Publication type:
- Article
Incidence trends of acute viral hepatitis caused by four viral etiologies between 1990 and 2019 at the global, regional and national levels.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2662, doi. 10.1111/liv.15452
- By:
- Publication type:
- Article
Hypochloremia as a novel adverse prognostic factor in acute liver failure.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2781, doi. 10.1111/liv.15449
- By:
- Publication type:
- Article
MAIT cells ameliorate liver fibrosis by enhancing the cytotoxicity of NK cells in cholestatic murine models.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2743, doi. 10.1111/liv.15445
- By:
- Publication type:
- Article
Hepatology in space: Effects of spaceflight and simulated microgravity on the liver.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2599, doi. 10.1111/liv.15444
- By:
- Publication type:
- Article
Non‐alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS‐NAFLD Study.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2632, doi. 10.1111/liv.15443
- By:
- Publication type:
- Article
Changing epidemiological features of hepatocellular carcinoma: Taiwan's position.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2911, doi. 10.1111/liv.15442
- By:
- Publication type:
- Article
Regulation of the macrophage‐hepatic stellate cell interaction by targeting macrophage peroxisome proliferator‐activated receptor gamma to prevent non‐alcoholic steatohepatitis progression in mice.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2696, doi. 10.1111/liv.15441
- By:
- Publication type:
- Article
Isotemporal substitution of different behaviour patterns with the presence of MAFLD in Chinese adults.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2683, doi. 10.1111/liv.15439
- By:
- Publication type:
- Article
Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2769, doi. 10.1111/liv.15438
- By:
- Publication type:
- Article
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2646, doi. 10.1111/liv.15437
- By:
- Publication type:
- Article
Outcomes of atezolizumab and bevacizumab for hepatocellular carcinoma: Does age matter?
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2597, doi. 10.1111/liv.15434
- By:
- Publication type:
- Article
Low anti‐HBc levels are associated with lower risk of virological relapse after nucleos(t)ide analogue cessation in HBe antigen‐negative patients.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2674, doi. 10.1111/liv.15433
- By:
- Publication type:
- Article
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2607, doi. 10.1111/liv.15432
- By:
- Publication type:
- Article
Response to 'Predictors of mid‐term survival after liver transplantation in patients with NAFLD cirrhosis'.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2914, doi. 10.1111/liv.15429
- By:
- Publication type:
- Article
Predictors of mid‐term survival after liver transplantation in patients with NAFLD cirrhosis.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2912, doi. 10.1111/liv.15427
- By:
- Publication type:
- Article
Response to 'Queries Regarding Medication Information and Influences on Bleeding and Clotting Events'.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Queries regarding medication information and influences on bleeding and clotting events.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2916, doi. 10.1111/liv.15425
- By:
- Publication type:
- Article
Author response: Improving patient‐provider communication by reducing stigma associated with liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2920, doi. 10.1111/liv.15423
- By:
- Publication type:
- Article
MAFLD: A quick fact check.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2903, doi. 10.1111/liv.15422
- By:
- Publication type:
- Article
Global cirrhosis prevalence trends and attributable risk factors–an ecological study using data from 1990–2019.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2791, doi. 10.1111/liv.15421
- By:
- Publication type:
- Article
Liver biopsy is associated with increased body weight loss in patients with non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2918, doi. 10.1111/liv.15420
- By:
- Publication type:
- Article
Natural history, spectrum and outcome of stage 3 AKI in patients with acute‐on‐chronic liver failure.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2800, doi. 10.1111/liv.15413
- By:
- Publication type:
- Article
No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2921, doi. 10.1111/liv.15407
- By:
- Publication type:
- Article
miR‐2392 serves as an immunological and prognostic biomarker in hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2923, doi. 10.1111/liv.15393
- By:
- Publication type:
- Article
Bcl‐x<sub>L</sub> as prognostic marker and potential therapeutic target in cholangiocarcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2855, doi. 10.1111/liv.15392
- By:
- Publication type:
- Article
The role of macrophage TAM receptor family in the acute‐to‐chronic progression of liver disease: From friend to foe?
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2620, doi. 10.1111/liv.15380
- By:
- Publication type:
- Article
The relevance of the liver volume increase after ALPPS.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2907, doi. 10.1111/liv.15376
- By:
- Publication type:
- Article
Authors' response to 'Liver growth prediction in ALPPS—A multicenter analysis from the international ALPPS registry'.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2908, doi. 10.1111/liv.15373
- By:
- Publication type:
- Article
Liver growth prediction in ALPPS – A multicenter analysis from the international ALPPS registry.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2815, doi. 10.1111/liv.15287
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2589, doi. 10.1111/liv.14962
- Publication type:
- Article